Developments in antithrombotic therapy: state of the art anno 1996
| Autor: | ten Cate H, Nurmohamed Mt, ten Cate Jw |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Hirudin Pharmaceutical Science Low molecular weight heparin Pharmacy Coronary Disease Pharmacology Toxicology Thrombin Fibrinolytic Agents Antithrombotic medicine Humans Pharmacology (medical) Platelet Intensive care medicine business.industry General Medicine medicine.disease Thrombosis business Venous thromboembolism medicine.drug |
| Zdroj: | ten Cate, H, Nurmohamed, M T & ten Cate, J W 1996, ' Developments in antithrombotic therapy : state of the art anno 1996 ', Pharmacy world & science : PWS, vol. 18, no. 6, pp. 195-203 . https://doi.org/10.1007/BF00735960 |
| ISSN: | 0928-1231 |
| Popis: | This review aims to discuss recent developments in antithrombotic therapy. New and specific inhibitors of platelet dependent thrombosis appear to moderately improve the outcome in coronary vascular disease. Further studies will need to address the cost-benefit ratio of this additional intervention. Hirudin and analogues are potent inhibitors of thrombin, and are clinically efficious, but at current dosage levels still complicated by bleeding. Low molecular weight heparin have markedly improved the efficacy of prevention and treatment of venous thromboembolism. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink